The SFTPD gene helps make surfactant protein D, a lung protein that helps the immune system recognize germs and supports a healthy balance of the fluid lining the air sacs. If this gene does not work well, the lungs may clear microbes less effectively and inflammation can become harder to control. This gene plays an important role in protecting delicate lung tissue during everyday breathing. Variants in the SFTPD gene are mainly studied in connection with asthma, chronic lung conditions, and breathing problems in newborns.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain processes happen, where they take place, and how strongly they run. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in LearnHub.
Overview
SFTPDGene function
What if the gene works
The SFTPD gene helps make surfactant protein D, which supports the lungs’ first line of defense. It helps clear germs and inhaled particles and helps keep inflammation in the air sacs more balanced.
Risk
What if the gene does not work
Changes in the SFTPD gene can reduce or alter surfactant protein D, a lung protein that helps tag germs and steady immune activity in the air sacs. Milder or more severe variants may leave function intact or disrupt this process.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the SFTPD gene is currently established. The SFTPD gene is being studied mainly as a biomarker of lung inflammation and infection, rather than as a guide to choosing a specific drug.
Gene function
What if the gene works
Every breath brings in dust, germs, and other tiny particles. The SFTPD gene helps the lungs manage this constant exposure by making surfactant protein D, a natural defense protein that sits on the moist surface of the air sacs. This helps explain what the SFTPD gene does in the lungs each day.
Surfactant protein D recognizes common surface patterns on inhaled bacteria, viruses, and fungi. This lets the lung’s first-line defenses respond in a more organized way.
It can stick to germs, dust, and cell debris and group them together. This makes it easier for immune cells in the air spaces to sweep them away.
This protein helps shape immune signals in the lungs. It supports a measured response that clears unwanted material while helping protect delicate air sac tissue.
Surfactant protein D is part of the surfactant system, the thin mixture that coats the air sacs. Within this layer, it helps keep the lung surface clean and ready to move oxygen into the blood.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SFTPD gene can change how surfactant protein D folds, assembles, or binds to sugars on germs and cell debris. In practical terms, how SFTPD gene variants affect surfactant protein D function depends on the change: milder variants may slightly lower protein stability or binding strength, while more severe variants can markedly reduce secretion or prevent normal multimer formation (the joining of many protein units). These effects can weaken its activity at the air surface of the lungs.
How variants are linked to conditions
Research on how variants in the SFTPD gene are linked to health conditions is still developing. The SFTPD gene does not yet have a broadly confirmed link to a specific medical condition, though this can change as evidence grows. Anyone with a confirmed SFTPD-related diagnosis should follow advice from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SFTPD, there is some evidence that lung irritants such as smoking, secondhand smoke, air pollution, and repeated chest infections can add to the risk of breathing-related problems. The effect of a specific SFTPD change can vary, so personal risk is shaped by both the gene change and everyday exposures.
Inheritance of SFTPD variants
For people looking into how SFTPD gene variants are inherited, there is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific SFTPD related condition. Most studied changes in the SFTPD gene have been linked to differences in risk, especially for some lung and infection related traits, rather than to a single condition with a clear autosomal dominant or autosomal recessive pattern. The SFTPD gene is located on chromosome 10, which is an autosome, so you inherit one copy of this gene from each parent.
What does my SFTPD result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for the SFTPD gene, though this understanding can change as research develops. If you have a specific SFTPD result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your health and family history.
Genetic information
Genetic testing
How you find out about variants
Variants in the SFTPD gene are found through genetic testing, usually using blood, saliva, or a cheek swab. In genetic testing for SFTPD gene variants, a lab reads the DNA code and compares it with known changes. Results may identify a benign variant, a variant linked to disease risk, or a variant of uncertain significance, meaning its effect is not clear.
When should I consider getting a genetic test?
There isn't yet a broadly established, SFTPD-specific clinical reason for genetic testing. Testing decisions are usually based on your personal and family history and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has little effect in another, or causes more side effects in someone else. Part of the reason is that the body breaks down, moves, or responds to drugs in slightly different ways based on inherited gene changes. These differences are common and can influence both how well a medication works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can affect the way a person responds to medication. By examining the relationship between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes influence how the body handles a drug or how strongly that drug works. This information can support more informed and more individualized treatment decisions. To explore this subject further, you can read more in the LearnHub.
Drugs influenced by the SFTPD gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor.
History
Researchers identified surfactant protein D in the late 1980s while studying proteins in the lung’s protective lining. Early work showed that it belonged to a small family of immune related proteins called collectins, which helped place it in a broader area of lung and infection research. From these first observations, research expanded steadily. During the 1990s, scientists mapped the SFTPD gene and linked it to growing interest in how the airways defend themselves. Later studies explored common genetic variants and how they might relate to differences in lung health and susceptibility to infections. Although the SFTPD gene has stayed mostly within specialist research, it has become an established part of the history of pulmonary and immune genetics.